These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7713138)

  • 1. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
    Gonzalez AM; Sibley DR
    Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
    Hillefors M; von Euler G
    Neurochem Int; 2001 Jan; 38(1):31-42. PubMed ID: 10913686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
    Millan MJ; Audinot V; Rivet JM; Gobert A; Vian J; Prost JF; Spedding M; Peglion JL
    Eur J Pharmacol; 1994 Aug; 260(2-3):R3-5. PubMed ID: 7988633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297.
    Rivet JM; Audinot V; Gobert A; Peglion JL; Millan MJ
    Eur J Pharmacol; 1994 Nov; 265(3):175-7. PubMed ID: 7875234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of D3 and sigma receptors in the rat striatum and nucleus accumbens using (+/-)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin and carbetapentane.
    Wallace DR; Booze RM
    J Neurochem; 1995 Feb; 64(2):700-10. PubMed ID: 7830063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
    Booze RM; Wallace DR
    Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.
    Levant B; Bancroft GN; Selkirk CM
    Synapse; 1996 Sep; 24(1):60-4. PubMed ID: 9046077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes.
    Clos MV; García-Sanz A; Vivas NM; Badia A
    Br J Pharmacol; 1997 Sep; 122(2):286-90. PubMed ID: 9313937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biphasic inhibition of stimulated endogenous dopamine release by 7-OH-DPAT in slices of rat nucleus accumbens.
    Patel J; Trout SJ; Palij P; Whelpton R; Kruk ZL
    Br J Pharmacol; 1995 Jun; 115(3):421-6. PubMed ID: 7582452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL; Schaus JM; Gehlert DR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1558-65. PubMed ID: 7562534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole binding and activation of cloned and expressed dopamine D2, D3 and D4 receptors.
    Mierau J; Schneider FJ; Ensinger HA; Chio CL; Lajiness ME; Huff RM
    Eur J Pharmacol; 1995 Jun; 290(1):29-36. PubMed ID: 7664822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ; Audinot V; Melon C; Newman-Tancredi A
    Eur J Pharmacol; 1995 Jul; 280(2):225-9. PubMed ID: 7589191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
    Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
    J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labeling of dopamine D3 and D4 receptor subtypes in human peripheral blood lymphocytes with [3H]7-OH-DPAT: a combined radioligand binding assay and immunochemical study.
    Ricci A; Bronzetti E; Felici L; Greco S; Amenta F
    J Neuroimmunol; 1998 Dec; 92(1-2):191-5. PubMed ID: 9916894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
    Malmberg ; Mikaels ; Mohell N
    J Pharmacol Exp Ther; 1998 Apr; 285(1):119-26. PubMed ID: 9536001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D3 receptor binding by D3 agonist 7-OH-DPAT (7-hydroxy-dipropylaminotetralin) and antipsychotic drugs measured ex vivo by quantitative autoradiography.
    Kaichi Y; Nonaka R; Hagino Y; Watanabe M
    Can J Physiol Pharmacol; 2000 Jan; 78(1):7-11. PubMed ID: 10741754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors.
    Svensson K; Carlsson A; Huff RM; Kling-Petersen T; Waters N
    Eur J Pharmacol; 1994 Oct; 263(3):235-43. PubMed ID: 7843260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS; Bergstrom DA; Gonzalez AM; Huang KX; Sibley DR; Walters JR
    Eur J Pharmacol; 1995 Apr; 277(2-3):209-14. PubMed ID: 7493610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.